✦ LIBER ✦

ChemInform Abstract: The Basal SAR of a Novel Insulin Receptor Activator.

✍ Scribed by Harold B. Wood Jr.; Regina Black; Gino Salituro; Deborah Szalkowski; Zhihua Li; Yan Zhang; David E. Moller; Bei Zhang; A. Brian Jones

Publisher: John Wiley and Sons
Year: 2000
Weight: 31 KB
Volume: 31
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200039111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: SAR of Novel Biaryl

ChemInform Abstract: SAR of Novel Biarylmethylamine Dopamine D4 Receptor Ligands.

✍ M. ARLT; H. BOETTCHER; A. RIETHMUELLER; G. SCHNEIDER; G. D. BARTOSZYK; H. GREINE 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 1 views

ChemInform Abstract: Discovery of a Pote

ChemInform Abstract: Discovery of a Potent, Highly Selective, and Orally Efficacious Small-Molecule Activator of the Insulin Receptor.

✍ Kun Liu; et al. et al. 📂 Article 📅 2000 🏛 John Wiley and Sons ⚖ 29 KB 👁 1 views

ChemInform Abstract: Structure-Based Des

ChemInform Abstract: Structure-Based Design, Synthesis and SAR of a Novel Series of Thiopheneamidine Urokinase Plasminogen Activator Inhibitors.

✍ Nalin Subasinghe; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

ChemInform Abstract: Discovery and Preli

ChemInform Abstract: Discovery and Preliminary SAR Studies of a Novel, Nonsteroidal Progesterone Receptor Antagonist Pharmacophore.

✍ C. L. F. POOLEY; J. P. EDWARDS; M. E. GOLDMAN; M.-W. WANG; K. B. MARSCHKE; D. L. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

In vitro and in vivo prevention of HIV p

In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activator

✍ Mingshan Cheng; Seiyu Chen; Steven R. Schow; Vara Prasad Manchem; Wayne R. Speva 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

## Abstract Protease inhibitor (PI) therapy for the treatment of patients infected with human immunodeficiency virus is frequently associated with insulin resistance and diabetic complications. These adverse effects of PI treatment result to a large extent from their inhibition of insulin‐stimulate

The insulin receptor as a universal mark

The insulin receptor as a universal marker of activated lymphocytes

✍ J. H. Helderman; T. C. Reynolds; T. B. Strom 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 742 KB